Article
Mesalazine pharmacokinetics and NAT2 phenotype.
European journal of clinical pharmacology - 1 Jan 2009
Lück Hendrik, Kinzig Martina, Jetter Alexander, Fuhr Uwe, Sörgel Fritz
Abstract excerpt
BACKGROUND: Mesalazine undergoes extensive metabolism by N-acetylation. While there is some evidence for an involvement of N-acetyltransferase (NAT) type 1, a potential role of NAT type 2 (NAT2) in vivo has not been tested. METHODS: In two studies in healthy young Caucasians, NAT2 phenotyping was carried out using a caffeine metabolic ratio in urine 4-6 h postdose. In study A, 1,000 mg mesalazine doses were given...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
